###### Key messages

What is already known about this subject?
=========================================

-   Emerging EULAR network (EMEUNET) and EULAR standing committee for education and training (ESCET) conducted the first systematic educational survey on the needs and preferences of young individuals working in the field of rheumatology in Europe.

What does this study add?
=========================

-   Young clinicians and physician researchers appreciated European League Against Rheumatism (EULAR\'s) current educational portfolio.

-   Participants were very much in favour of new educational courses on imaging techniques, as well as general review and refresher courses.

-   Lack of funding was considered the major obstacle to participating in existing EULAR programmes.

How might this impact on clinical practice?
===========================================

-   The results from this survey will help to develop EULAR\'s future educational portfolio.

Introduction {#s1}
============

Diligent medical education and scientific training in rheumatology enables young clinicians and physician researchers to provide the highest standards of care and develop new treatment strategies for patients with rheumatic and musculoskeletal diseases. Well-trained young individuals are essential for the prosperity of the European rheumatology community, prompting the European League Against Rheumatism (EULAR) to identify education and training as one of its key strategic activities.[@R1] In addition to country-specific schedules that govern the educational standards of young individuals,[@R1] EULAR offers courses and educational materials that cover niches or complement national training programmes.[@R1]

Medical care in rheumatology is changing rapidly, which creates new educational needs. In addition, novel training technologies are evolving quickly. Online courses and podcasts can bring knowledge from world-leading experts to the offices of young individuals worldwide. Almost 10 years ago, EULAR launched the first online course on rheumatic diseases, which has become one of EULAR\'s most successful training programmes.[@R1]

The rapid changes in medical care and learning technologies prompted us to reach out to a large number of young European physicians and scientists working in the field of rheumatology to assess (1) the awareness and acceptance of the current EULAR portfolio, (2) the access to EULAR training opportunities and (3) the unmet educational needs.

Methods {#s2}
=======

Development and distribution of the survey {#s2a}
------------------------------------------

The survey was a joint venture of the EULAR standing committee for education and training (ESCET) and the Emerging EULAR network (EMEUNET). The EMEUNET education subgroup piloted the survey, which was reviewed by the EMEUNET working group and ESCET. The final version of the survey was uploaded on SurveyMonkey (complete survey available on request) and email invitations were sent to all EMEUNET members. In addition, EMEUNET country liaisons distributed invitations within national groups of young clinicians and researchers. After the initial invitation, three reminders were sent using the same distribution strategy. Individuals below the age of 40 years performing clinical and/or scientific work in the field of rheumatology were asked to participate. The intended time length of the survey was a maximum of 15 min to ensure high participation and completion rates. The survey mainly assessed categorical responses. At the end of each assessment (eg, awareness of educational programmes or access to educational programmes), participants were invited to provide additional open comments. Data were collected between November 2013 and March 2014.

Data handling {#s2b}
-------------

For all participants, individual responses were checked for completeness. If respondents did not fully answer the questions on basic characteristics including demographics, work and research focus, they were excluded from further analysis. For the specific assessments of clinical or scientific educational needs, participants were allowed to complete or skip the respective section in order to avoid unnecessary questions.

All participants were categorised as 'clinician', 'researcher' or 'physician researcher', with the latter performing both research and clinical work. Clinicians and physician researchers were further categorised according to: (1) clinical position and (2) country of origin, which was further allocated to one of the three following groups according to the gross domestic product (GDP) per capita 2014[@R5] as follows: Group 1: Norway, Switzerland, Denmark, Sweden, Ireland, the Netherlands, Austria, Belgium, Germany, UK, France, Italy, Andorra; Group 2: Spain, Cyprus, Malta, Slovenia, Portugal, Greece, Estonia, Czech Republic, Slovakia, Lithuania, Latvia, Poland, Hungary; Group 3: Croatia, Russia, Turkey, Romania, Belarus, Azerbaijan, Bulgaria, Serbia, Albania, Georgia, Ukraine, Moldova.

Statistical analysis {#s2c}
--------------------

Of a total of 773 participants, 728 completed the questions on basic characteristics and were included in the first analysis. Given the different background and educational needs, participants from outside Europe and those whose work status was 'researcher' were then excluded, resulting in a selection of young European clinicians and physician researchers. Categorical variables were compared across groups with the χ^2^ test. Continuous variables were compared across three groups using one-way analysis of variance (ANOVA). For all analyses, p values \<0.05 were considered significant. Statistical analysis was carried out using IBM SPSS Statistics V.21 (IBM Deutschland GmbH, Ehningen, Germany) and GraphPadPrism V.5.03 (GraphPad Software, San Diego, California, USA). Open answers and comments were not analysed systematically.

Results {#s3}
=======

Characteristics of participants {#s3a}
-------------------------------

Ninety per cent of all participants were from Europe (N=656), with the highest number of respondents coming from Spain (14%) and France (8%) (see online [supplementary table](#SM1){ref-type="supplementary-material"} S1). We observed a female predominance (68%), and most of the participants were between 25 and 35 years (76%) of age (see online [supplementary table](#SM1){ref-type="supplementary-material"} S2). Most participants\' work status was 'physician researcher' (53%), defined as someone who performs both clinical work and research, followed by 'clinician' (34%) and 'researcher' (13%) (see online [supplementary table](#SM1){ref-type="supplementary-material"} S2). In their clinical work, most participants were trainees or young consultants in rheumatology (90%). The majority of participants hold a research position as a PhD candidate, postdoctoral or junior researcher (86%), while only a few Master\'s students or senior researchers participated in the survey (see online [supplementary table](#SM1){ref-type="supplementary-material"} S2). A total of 568 participants were included in the detailed analysis after excluding 72 participants from non-European countries and 88 non-clinical scientists.

10.1136/rmdopen-2015-000240.supp1

Regarding their daily schedule, clinicians spent 74±18% of their time in clinical work. Physician researchers also spent most of their time in clinical work (59±22%) while they used 23±20% of their time for research (see online [supplementary figure](#SM2){ref-type="supplementary-material"} S1). Overall, participants dedicated less time to teaching (14±13%) and little time to administration (5±9%). While physician researchers performed clinical/epidemiological (78%), basic (24%) and/or translational research (17%), most clinicians (51%) did not carry out research. Asked about their career plans, clinicians and physician researchers both showed the highest interest in pursuing a clinical career, followed by an academic career or career in private practice. Both clinicians and physician researchers indicated little interest in working in industry, independent from their clinical position (see online [supplementary table](#SM1){ref-type="supplementary-material"} S4).

10.1136/rmdopen-2015-000240.supp2

###### 

Time dedicated to different tasks

Awareness and access to existing educational programmes {#s3b}
-------------------------------------------------------

The general awareness of the existing educational programmes under the EULAR umbrella was high for the well-established programmes, although the participation rates were modest. Thirty-two per cent of all participants had already participated in the EULAR online course on rheumatic diseases and 13% in the EULAR postgraduate course ([table 1](#RMDOPEN2015000240TB1){ref-type="table"}A). The participation rate in the EULAR online course on rheumatic diseases was similar between trainees in rheumatology and young consultants, the most frequent clinical positions held by the survey participants. In contrast, participation of young consultants at the EULAR postgraduate course, a live course, exceeded that of trainees in rheumatology ([table 1](#RMDOPEN2015000240TB1){ref-type="table"}B, C). Of note, participation rates in the EULAR online course on rheumatic diseases and the EULAR postgraduate course were higher among young individuals from countries with a lower GDP (group 3; [table 1](#RMDOPEN2015000240TB1){ref-type="table"}D, E). This trend was reversed, however, for the more competitive programmes, such as the ACR/EULAR exchange programme and the EUREKA course of Translational medicine, although the very low numbers of participants in these training opportunities do not allow one to draw final conclusions (see online [supplementary figure](#SM2){ref-type="supplementary-material"} S9).

###### 

Awareness of existing programmes

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic\                                       Have never heard of\   Have heard of\   Would like to participate in\   Have strong interest in\   Have participated in\   Σ\          χ^2^,\
  *Clinicians and physician researchers*                N (%)                  N (%)            N (%)                           N (%)                      N (%)                   N (%)       p value
  ----------------------------------------------------- ---------------------- ---------------- ------------------------------- -------------------------- ----------------------- ----------- ---------
  *(a) All participants*                                                                                                                                                                       

  EULAR online course                                   55 (10)                78 (14)          112 (21)                        125 (23)                   174 (32)                544 (100)   NA

  EULAR online course on Connective Tissue Diseases     79 (15)                146 (27)         146 (27)                        155 (29)                   18 (3)                              

  EULAR/EUSTAR online course on SSc                     87 (16)                161 (30)         146 (27)                        122 (22)                   28 (5)                              

  EULAR ultrasound online course                        93 (17)                134 (25)         117 (22)                        152 (28)                   48 (9)                              

  EULAR postgraduate course                             118 (22)               125 (23)         107 (20)                        121 (22)                   73 (13)                             

  EULAR epidemiology course                             141 (26)               178 (33)         110 (20)                        84 (15)                    31 (6)                              

  ACR/EULAR exchange programme                          208 (38)               142 (26)         89 (16)                         98 (18)                    7 (1)                               

  EUREKA course of Translational Medicine               277 (51)               130 (24)         83 (15)                         46 (9)                     8 (2)                               

  EUSTAR SSc course                                     187 (34)               139 (26)         92 (17)                         98 (18)                    28 (5)                              

  EULAR course on capillaroscopy                        127 (23)               159 (29)         114 (21)                        121 (22)                   23 (4)                              

  EULAR ultrasound course                               78 (14)                112 (21)         107 (20)                        197 (36)                   50 (9)                              

  *(b) EULAR online course---clinical position*                                                                                                                                                

  Medical student                                       3 (38)                 2 (25)           3 (38)                          0 (0)                      0 (0)                   8 (100)     \<0.001

  Trainee (internal m.)                                 6 (14)                 9 (21)           11 (25)                         9 (21)                     9 (21)                  44 (100)    

  Trainee (rheum.)                                      32 (11)                34 (11)          54 (18)                         79 (26)                    102 (34)                301 (100)   

  Young consultant                                      14 (7)                 33 (17)          44 (23)                         37 (19)                    63 (33)                 191 (100)   

  *(c) EULAR postgraduate course---clinical position*                                                                                                                                          

  Medical student                                       4 (50)                 4 (50)           0 (0)                           0 (0)                      0 (0)                   8 (100)     \<0.001

  Trainee (internal m.)                                 20 (45)                7 (16)           9 (20)                          5 (11)                     3 (7)                   44 (100)    

  Trainee (rheum.)                                      74 (25)                65 (22)          60 (20)                         73 (24)                    29 (10)                 301 (100)   

  Young consultant                                      20 (11)                49 (26)          38 (20)                         43 (23)                    41 (22)                 191 (100)   

  *(d) EULAR online course---country of origin*                                                                                                                                                

  Group 1                                               27 (12)                40 (18)          50 (23)                         40 (19)                    65 (29)                 222 (100)   0.118

  Group 2                                               23 (10)                31 (14)          45 (20)                         56 (25)                    74 (32)                 229 (100)   

  Group 3                                               4 (4)                  7 (8)            17 (19)                         29 (32)                    35 (38)                 92 (100)    

  *(e) EULAR postgraduate course---country of origin*                                                                                                                                          

  Group 1                                               79 (35)                59 (27)          33 (15)                         39 (18)                    12 (5)                  222 (100)   \<0.001

  Group 2                                               32 (14)                53 (23)          51 (22)                         54 (24)                    39 (17)                 229 (100)   

  Group 3                                               7 (8)                  12 (13)          23 (25)                         28 (30)                    22 (24)                 92 (100)    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(a--e) Total sample with N=656 participants of whom 544 responded to this part of the survey. Values are expressed as absolute numbers and percentages in brackets as N (%).

\(a\) Analysis with all responses. (b, c) Analysis on categorisation of participants according to clinical position. (d, e) Analysis on categorisation of participants according to country of origin. Countries allocated to groups 1--3 according to the GDP per capita 2014. Group 1: Norway, Switzerland, Denmark, Sweden, Ireland, the Netherlands, Austria, Belgium, Germany, UK, France, Italy, Andorra; Group 2: Spain, Cyprus, Malta, Slovenia, Portugal, Greece, Estonia, Czech Republic, Slovakia, Lithuania, Latvia, Poland, Hungary; Group 3: Croatia, Russia, Turkey, Romania, Belarus, Azerbaijan, Bulgaria, Serbia, Albania, Georgia, Ukraine, Moldova.

ACR, American College of Rheumatology; EULAR, European League Against Rheumatism; EUSTAR, European Scleroderma Trial and Research Organization; GDP, gross domestic product; internal m, internal medicine; NA, not applicable; rheum, rheumatism; SSc, systemic sclerosis.

The current EULAR educational programme was very well received by the survey participants: a majority of 64% disagreed with the statement that the EULAR educational programme did not cover their needs, while only 3% were in full agreement ([table 2](#RMDOPEN2015000240TB2){ref-type="table"}A). Acceptance rates were even higher among young consultants with up to 71% disagreeing with the aforementioned statement ([table 2](#RMDOPEN2015000240TB2){ref-type="table"}D). Lack of funding opportunities was considered the predominant obstacle to participation: 58% of participants fully or mostly agreed that they cannot afford their educational needs on their own. In addition, 45% fully or mostly agreed that they do not have access to institutional funding, and 39% that they do not have enough alternative means of funding ([table 2](#RMDOPEN2015000240TB2){ref-type="table"}A). In this regard, trainees in internal medicine, trainees in rheumatology and young consultants indicated a similar lack of funding for their educational needs ([table 2](#RMDOPEN2015000240TB2){ref-type="table"}C). As expected, individuals from countries with a lower GDP more frequently experienced problems with course funding ([table 2](#RMDOPEN2015000240TB2){ref-type="table"}F). Finally, participants considered lack of timely information about ongoing educational opportunities and lack of leave from work as minor obstacles to participating in the EULAR educational programme ([table 2](#RMDOPEN2015000240TB2){ref-type="table"}A--G).

###### 

Access to existing programmes

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic\                                                                                         Fully agree\   Mostly agree\   Partially agree\   Do not agree\   Undecided\   Σ\          χ^2^,\
  *Clinicians and physician researchers*                                                                  N (%)          N (%)           N (%)              N (%)           N (%)        N (%)       p value
  ------------------------------------------------------------------------------------------------------- -------------- --------------- ------------------ --------------- ------------ ----------- ---------
  *(a) All participants*                                                                                                                                                                             

  I do not have enough and timely information about ongoing projects                                      61 (11)        116 (22)        187 (35.1)         144 (27.0)      25 (5)       533 (100)   NA

  I cannot afford my educational needs on my own                                                          157 (30)       151 (28)        130 (24)           75 (14)         20 (4)                   

  My department does not provide me enough leave to participate in                                        69 (13)        100 (19)        169 (32)           178 (33)        17 (32)                  

  I do not have access to departmental/institutional funding                                              105 (20)       135 (25)        151 (28)           114 (21)        28 (5)                   

  I do not have access to alternative means of funding                                                    74 (14)        132 (25)        176 (33)           127 (24)        24 (5)                   

  The current EULAR educational programme does not cover my educational needs                             14 (3)         25 (4.7)        88 (17)            341 (64)        65 (12)                  

  *(b) I do not have enough and timely information about ongoing projects---clinical position*                                                                                                       

  Medical student                                                                                         1 (17)         1 (17)          1 (17)             3 (50)          0 (0)        6 (100)     \<0.001

  Trainee (internal m.)                                                                                   7 (16)         10 (23)         15 (35)            9 (21)          2 (5)        43 (100)    

  Trainee (rheum.)                                                                                        39 (13)        68 (23)         107 (36)           67 (23)         16 (5)       297 (100)   

  Young consultant                                                                                        15 (8)         37 (20)         64 (34)            67 (36)         4 (2)        187 (100)   

  *(c) I cannot afford my educational needs on my own---clinical position*                                                                                                                           

  Medical student                                                                                         1 (17)         1 (17)          2 (33)             0 (0)           2 (33)       6 (100)     \<0.001

  Trainee (internal m.)                                                                                   11 (26)        14 (33)         12 (28)            2 (5)           4 (9)        43 (100)    

  Trainee (rheum.)                                                                                        93 (30)        84 (27)         70 (22)            42 (14)         8 (3)        297 (100)   

  Young consultant                                                                                        52 (28)        52 (28)         46 (25)            31 (17)         6 (3)        187 (100)   

  *(d) The current EULAR educational programme does not cover my educational needs---clinical position*                                                                                              

  Medical student                                                                                         0 (0)          1 (17)          1 (17)             1 (17)          3 (50)       6 (100)     \<0.001

  Trainee (internal m.)                                                                                   0 (0)          3 (7)           5 (12)             27 (63)         8 (19)       43 (100)    

  Trainee (rheum.)                                                                                        10 (3)         16 (5)          52 (18)            181 (61)        38 (13)      297 (100)   

  Young consultant                                                                                        4 (2)          5 (3)           30 (16)            132 (71)        16 (9)       187 (100)   

  *(e) I do not have enough and timely information about ongoing projects---country of origin*                                                                                                       

  Group 1                                                                                                 22 (10)        52 (24)         81 (38)            49 (23)         12 (6)       216 (100)   0.525

  Group 2                                                                                                 29 (13)        47 (21)         77 (34)            61 (27)         11 (5)       225 (100)   

  Group 3                                                                                                 10 (11)        17 (19)         29 (32)            34 (37)         2 (2)        92 (100)    

  *(f) I cannot afford my educational needs on my own---country of origin*                                                                                                                           

  Group 1                                                                                                 37 (17)        71 (33)         61 (28)            36 (17)         11 (5)       216 (100)   0.525

  Group 2                                                                                                 72 (32)        65 (29)         52 (23)            28 (12)         8 (4)        225 (100)   

  Group 3                                                                                                 48 (52)        15 (16)         17 (19)            11 (12)         1 (1)        92 (100)    

  *(g) The current EULAR educational programme does not cover my educational needs---country of origin*                                                                                              

  Group 1                                                                                                 4 (2)          10 (5)          36 (17)            132 (61)        34 (16)      216 (100)   0.690

  Group 2                                                                                                 6 (3)          11 (5)          32 (14)            153 (68)        23 (10)      225 (100)   

  Group 3                                                                                                 4 (4)          4 (4)           20 (22)            56 (61)         8 (9)        92 (100)    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(a--g) Total sample with N=656 participants of whom 533 responded to this part of the survey. Values are expressed as absolute numbers and percentages in brackets as N (%).

\(a\) Analysis with all responses. (b--d) Analysis on categorisation of participants according to clinical position. (e--g) Analysis on categorisation of participants according to country of origin. Countries allocated to groups 1--3 according to the GDP per capita 2014. Group 1: Norway, Switzerland, Denmark, Sweden, Ireland, The Netherlands, Austria, Belgium, Germany, UK, France, Italy, Andorra; Group 2: Spain, Cyprus, Malta, Slovenia, Portugal, Greece, Estonia, Czech Republic, Slovakia, Lithuania, Latvia, Poland, Hungary; Group 3: Croatia, Russia, Turkey, Romania, Belarus, Azerbaijan, Bulgaria, Serbia, Albania, Georgia, Ukraine, Moldova.

EULAR, European League Against Rheumatism; GDP, gross domestic product; NA, not applicable.

Interests and needs of participants {#s3c}
-----------------------------------

When asked about their needs and interests, participants were allowed to skip the clinical or scientific assessment. Nevertheless, clinicians and physician researchers showed high interest in clinical (91%) and scientific (81%) educational programmes (data not shown). Regarding dedicated clinical courses, the majority of participants indicated interest or strong interest in imaging studies, including X-ray (90%), ultrasound (88%) and MRI (87%), as well as for refresher courses (97%) and general review (95%) ([table 3](#RMDOPEN2015000240TB3){ref-type="table"}). When asked about scientific training, responses from the participants were more diverse: interest or strong interest was expressed particularly for courses on statistics (85%), research methodology (83%) and presentation skills (80%) ([table 3](#RMDOPEN2015000240TB3){ref-type="table"}).

###### 

Interests in specific training programmes

  ----------------------------------------------------------------------------------------------------------------------------
  Characteristic\                            No interest\   Little interest\   Interested in\   Strong interest\   Σ\
  Clinicians and physician researchers       N (%)          N (%)              N (%)            N (%)              N (%)
  ------------------------------------------ -------------- ------------------ ---------------- ------------------ -----------
  *(a) Clinical training programmes*                                                                               

  Specific techniques                                                                                              

   Communication skills                      59 (12)        135 (28)           187 (39)         96 (20)            477 (100)

   Clinical examination                      22 (4)         54 (11)            197 (41)         204 (43)           

   Capillaroscopy                            42 (9)         115 (24)           175 (37)         145 (30)           

   Arthrocentesis                            38 (8)         83 (17)            166 (35)         190 (40)           

   Synovial fluid analysis                   30 (6)         96 (20)            205 (43)         146 (30)           

   Urine analysis                            107 (22)       185 (39)           129 (27)         56 (12)            

   Ultrasound                                13 (3)         45 (9)             120 (25)         299 (63)           

   X-ray evaluation                          10 (2)         40 (8)             193 (41)         234 (49)           

   MRI                                       11 (2)         48 (10)            202 (42)         216 (45)           

   Laboratory evaluations                    29 (6)         79 (17)            194 (41)         175 (37)           

   Biopsy                                    42 (2)         101 (21)           169 (35)         165 (35)           

  General courses                                                                                                  

   Review courses on rheumatic diseases      5 (1)          19 (4)             190 (40)         263 (55)           

   Refreshers/updates                        5 (1)          8 (2)              176 (37)         288 (60)           

  *(b) Scientific training programmes*                                                                             

  General background                         10 (2)         69 (16)            220 (52)         122 (29)           421 (100)

  Experimental techniques                    36 (6)         117 (28)           183 (44)         109 (20)           

  Research methodology (epidemiology, etc)   15 (4)         59 (14)            197 (47)         150(36)            

  Writing skills                             17 (4)         67 (16)            199 (47)         138 (33)           

  Reviewing skills                           19 (5)         59 (14)            201 (48)         142 (34)           

  Presentation skills                        18 (4)         68 (16)            172 (41)         163 (39)           

  Statistics (theory and practice)           12 (3)         50 (12)            170 (40)         189 (45)           
  ----------------------------------------------------------------------------------------------------------------------------

Researchers were allowed to participate in or skip the assessment on clinical training programmes; clinicians were allowed to participate in or skip the assessment on scientific training programmes. Upper part: All participants interested in clinical training programmes (N=477) responded to the assessment. Lower part: All participants interested in scientific training programmes (N=421) responded to the assessment. Values are expressed as total numbers and percentages in brackets as N (%).

Finally, we observed a diversity of individual preferences when interviewing participants for their preferred learning modalities. Interests in attending live courses and conferences for learning purposes were higher compared to other learning modalities (see online [supplementary table](#SM1){ref-type="supplementary-material"} S5). Eighty-five per cent of participants preferred or strongly preferred participation in live courses and 84% case-oriented and problem-oriented learning.

Discussion {#s4}
==========

The current survey assessed the educational needs of young individuals in rheumatology to define and foster future educational opportunities. The survey stands out for its large sample size with around 600 participants from 38 European countries. We addressed a broad spectrum of educational details and obtained the following key findings: The current educational portfolio of EULAR is well perceived among young individuals in the field, which is in line with results from a small previous study.[@R3] Bandinelli *et al*[@R3] observed a very high acceptance rate for the EULAR online course on rheumatic diseases among 170 young rheumatologists across Europe. Together, these findings reinforce EULAR\'s educational policy.Lack of financial means is the major obstacle preventing participation in existing EULAR educational programmes. As expected, lack of funding opportunities is a greater issue in countries with a lower GDP per capita. Along with our findings, Gaujoux-Viala *et al*[@R6] revealed financial support by bursaries as one of the most important needs of 243 young rheumatologists. To compensate for these financial needs, EULAR has reduced the costs for the online courses and offers course bursaries for its live courses. Future funding opportunities might include educational funds from government or industry.The outstanding interest in imaging modalities (ultrasound, X-ray, MRI) may prompt EULAR to expand its imaging educational programme even beyond the ultrasound courses. EULAR\'s future scientific courses might teach statistics, presentation skills and research methodologies, as these were among the main interests of young rheumatologists and researchers.While learning preferences were diverse, live courses and live conferences were very much favoured by our participants. This piece of information may raise EULAR\'s awareness of 'classical' live teaching programmes, which may not always be replaceable by online teaching opportunities.The survey participants showed a strong interest in pursuing a career in academia and in clinical environments, suggesting that EULAR invests in those young individuals who will represent EULAR and the European rheumatology community in future.

Our survey was subject to structural limitations: First, the proportion of (non-physician) researchers was very small within the study, reflecting that EMEUNET and EULAR mainly represent physicians and physician researchers and compelling us to exclude those individuals for the detailed analyses of this survey. Second, EMEUNET members or individuals linked to the EMEUNET network were more likely to receive invitations and participate in the survey, with 46% of participants being indeed a member of EMEUNET. This might result in a predominance of academia-oriented responders. Second, using the EMEUNET network to distribute invitations to participate in the survey, we could not determine the number of individuals who had finally received our invitations. Finally, country-specific response rates depended on pre-existing networks for young rheumatologists that helped to invite participants. Although the use of the EMEUNET network resulted in many limitations of our study, we had already learnt in an earlier study[@R4] that this network was the only available approach to reach out to young individuals all over Europe: In a lot of European countries, national associations for medicine and rheumatology could provide neither educational information nor contact details of young individuals working in the field. In this context, we wish that this survey may pioneer future educational studies, which will exceed our current work in completeness and unbiasedness of data by collecting information from nationally registered young individuals in training for rheumatology.

Taken together, this large survey among around 600 young individuals working in the field of rheumatology reveals a high acceptance rate of the current EULAR educational portfolio. Training on novel imaging technologies is among the most important educational needs of these young individuals and cost-effective educational opportunities as well as live courses are much appreciated.

Special thanks to Gabriela Kluge, EULAR Education Programme manager, for her constant support in performing this survey. Many thanks to all young clinicians and researchers who participated in the online survey.
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